Capricor Therapeutics, Inc. (CAPR)
8.95
+0.01
(+0.11%)
USD |
NASDAQ |
Oct 02, 16:00
9.02
+0.07
(+0.78%)
After-Hours: 20:00
Capricor Therapeutics Price : 8.95 for Oct. 2, 2026
Price Chart
Historical Price Data
| Date | Open | High | Low | Close | Volume |
|---|---|---|---|---|---|
| Oct 02, 2026 | 9.14 | 9.24 | 8.770 | 8.95 | 2.639M |
| Oct 01, 2026 | 9.36 | 9.394 | 8.83 | 8.94 | 3.876M |
| Sep 30, 2026 | 10.03 | 10.72 | 9.40 | 9.47 | 20.57M |
| Sep 29, 2026 | 8.745 | 8.970 | 8.50 | 8.57 | 2.675M |
| Sep 28, 2026 | 8.29 | 8.840 | 8.152 | 8.71 | 2.097M |
| Sep 25, 2026 | 8.61 | 8.67 | 8.30 | 8.36 | 1.920M |
| Sep 24, 2026 | 8.60 | 8.865 | 8.27 | 8.57 | 2.402M |
| Sep 23, 2026 | 9.26 | 9.36 | 8.52 | 8.67 | 3.147M |
| Sep 22, 2026 | 9.01 | 9.48 | 8.89 | 9.34 | 2.500M |
| Sep 21, 2026 | 9.14 | 9.275 | 8.84 | 8.90 | 2.419M |
| Sep 18, 2026 | 9.295 | 9.359 | 8.96 | 9.06 | 3.256M |
| Sep 17, 2026 | 8.93 | 9.79 | 8.82 | 9.42 | 3.940M |
| Sep 16, 2026 | 8.58 | 9.07 | 8.41 | 8.56 | 2.386M |
| Sep 15, 2026 | 8.83 | 8.90 | 8.375 | 8.56 | 2.175M |
| Sep 14, 2026 | 9.105 | 9.24 | 8.71 | 8.81 | 2.908M |
| Sep 11, 2026 | 8.32 | 8.67 | 8.26 | 8.37 | 2.075M |
| Sep 10, 2026 | 8.575 | 8.70 | 8.182 | 8.30 | 2.917M |
| Sep 09, 2026 | 9.08 | 9.27 | 8.60 | 8.64 | 2.751M |
| Sep 08, 2026 | 9.15 | 9.488 | 8.81 | 9.06 | 2.728M |
| Sep 04, 2026 | 9.40 | 9.81 | 9.26 | 9.40 | 2.556M |
| Sep 03, 2026 | 9.83 | 9.93 | 9.14 | 9.28 | 4.065M |
| Sep 02, 2026 | 10.07 | 10.65 | 9.60 | 9.89 | 5.165M |
| Sep 01, 2026 | 10.77 | 11.00 | 9.85 | 10.01 | 6.309M |
| Aug 31, 2026 | 9.495 | 10.27 | 9.065 | 9.91 | 4.559M |
| Aug 28, 2026 | 9.73 | 10.20 | 9.47 | 9.59 | 5.186M |
Price Definition
The price of a security measures the cost to purchase 1 share of a security. For a company, price can be multiplied by shares outstanding to find the market capitalization (value of the company).
Price Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Price Benchmarks
| ARS Pharmaceuticals, Inc. | 4.07 |
| SELLAS Life Sciences Group, Inc. | 11.74 |
| Sionna Therapeutics, Inc. | 4.91 |
| Alnylam Pharmaceuticals, Inc. | 219.72 |
| Cytokinetics, Inc. | 65.60 |
Price Related Metrics
| PEG Ratio | -0.0742 |
| Price to Book Value | 2.112 |
| Earnings Yield | -27.37% |
| Market Cap | 520.08M |
| PEGY Ratio | -0.0742 |